Two Executives Named To Bellrock Board
William Pocklington and Paul Schmitt were named to the board of directors of Bellrock Intelligence, which is a SaaS decision support company with a platform based on intelligence sector know-how.
Pocklington, an independent business advisor and investor, most recently was vice president at Change Healthcare, one of the largest and most innovative independent healthcare technology companies in the U.S. Previously he was vice president of sales at McKesson Health Solutions, where he led sales for the eastern region for the company’s financial management and network management product lines.
Schmitt is a CEO and investor who has spearheaded the formation and growth of two public and three private companies. He has raised more than $500 million in growth capital financing and led numerous transactions, including IPOs, mergers, acquisitions, divestitures, licenses and joint ventures. A trustee of the Wistar Institute in Philadelphia, he also serves on the boards of GelMed Sciences, JBS United Animal Health JV, and Cernostics, where he serves as chairman. He is also the Amorcyte shareholder representative to Caladrius.